Karl R. Clauser

28.2k total citations · 8 hit papers
84 papers, 11.6k citations indexed

About

Karl R. Clauser is a scholar working on Molecular Biology, Spectroscopy and Oncology. According to data from OpenAlex, Karl R. Clauser has authored 84 papers receiving a total of 11.6k indexed citations (citations by other indexed papers that have themselves been cited), including 67 papers in Molecular Biology, 36 papers in Spectroscopy and 14 papers in Oncology. Recurrent topics in Karl R. Clauser's work include Advanced Proteomics Techniques and Applications (34 papers), Mass Spectrometry Techniques and Applications (18 papers) and Glycosylation and Glycoproteins Research (10 papers). Karl R. Clauser is often cited by papers focused on Advanced Proteomics Techniques and Applications (34 papers), Mass Spectrometry Techniques and Applications (18 papers) and Glycosylation and Glycoproteins Research (10 papers). Karl R. Clauser collaborates with scholars based in United States, Australia and United Kingdom. Karl R. Clauser's co-authors include Steven A. Carr, Richard O. Hynes, Alexandra Naba, Alma L. Burlingame, Vamsi K. Mootha, Sarah E. Calvo, Peter R. Baker, D.R. Mani, Charles A. Whittaker and Hui Liu and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Karl R. Clauser

84 papers receiving 11.4k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices

2011 903 citations Alexandra Naba, Karl R. Clauser et al. Molecular & Cellular Proteomics profile →
MitoCarta2.0: an updated inventory of mammalian mitochondrial proteins

2015 903 citations Sarah E. Calvo, Karl R. Clauser et al. profile →
Role of Accurate Mass Measurement (±10 ppm) in Protein Identification Strategies Employing MS or MS/MS and Database Searching

1999 901 citations Karl R. Clauser et al. profile →
Dimerization of the Extracellular Domain of the Human Growth Hormone Receptor by a Single Hormone Molecule

1991 730 citations Karl R. Clauser, James A. Wells et al. Science profile →
The extracellular matrix: Tools and insights for the “omics” era

2015 729 citations Alexandra Naba, Karl R. Clauser et al. profile →
Integrated proteomic analysis of post-translational modifications by serial enrichment

2013 471 citations Philipp Mertins, Jana Qiao et al. profile →
Mass Spectrometry Profiling of HLA-Associated Peptidomes in Mono-allelic Cells Enables More Accurate Epitope Prediction

2017 406 citations Jennifer G. Abelin, Thomas Eisenhaure et al. Immunity profile →
Proteomic analyses of ECM during pancreatic ductal adenocarcinoma progression reveal different contributions by tumor and stromal cells

2019 291 citations Chenxi Tian, Karl R. Clauser et al. profile →

Peers

Countries citing papers authored by Karl R. Clauser

Since Specialization

Citations

This map shows the geographic impact of Karl R. Clauser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karl R. Clauser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karl R. Clauser more than expected).

Fields of papers citing papers by Karl R. Clauser

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karl R. Clauser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karl R. Clauser. The network helps show where Karl R. Clauser may publish in the future.

Co-authorship network of co-authors of Karl R. Clauser

This figure shows the co-authorship network connecting the top 25 collaborators of Karl R. Clauser. A scholar is included among the top collaborators of Karl R. Clauser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karl R. Clauser. Karl R. Clauser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Pan-viral ORFs discovery using massively parallel ribosome profiling 2025 ·Science ·Shira Weingarten-Gabbay, Matthew R. Bauer, Alexandra C. Stanton, Yingpu Yu, Catherine A. Freije, (unknown), Chloe K. Boehm, Susan Klaeger, (unknown), Daniel López, Lisa E. Hensley, Karl R. Clauser, Steven A. Carr, Jennifer G. Abelin, Charles M. Rice, Pardis C. Sabeti	1
2	Sensitive, High-Throughput HLA-I and HLA-II Immunopeptidomics Using Parallel Accumulation-Serial Fragmentation Mass Spectrometry 2023 ·Molecular & Cellular Proteomics ·(unknown), Claudia Ctortecka, Alvaro Sebastian Vaca Jácome, Susan Klaeger, (unknown), (unknown), Namrata D. Udeshi, Karl R. Clauser, Jennifer G. Abelin, Steven A. Carr	23
3	HLA-II immunopeptidome profiling and deep learning reveal features of antigenicity to inform antigen discovery 2023 ·Immunity ·Martin Stražar, Jihye Park, Jennifer G. Abelin, (unknown), (unknown), Damian R. Plichta, Eric Brown, Basak Eraslan, (unknown), (unknown), Karl R. Clauser, Steven A. Carr, Ramnik J. Xavier, Daniel B. Graham	20
4	Proteomic Profiling of Extracellular Matrix Components from Patient Metastases Identifies Consistently Elevated Proteins for Developing Nanobodies That Target Primary Tumors and Metastases 2023 ·Cancer Research ·Noor Jailkhani, Karl R. Clauser, (unknown), Steffen Rickelt, Chenxi Tian, Charles A. Whittaker, Kenneth K. Tanabe, (unknown), Steven A. Carr, Richard O. Hynes	15
5	What Can Ribo-Seq, Immunopeptidomics, and Proteomics Tell Us About the Noncanonical Proteome? 2023 ·Molecular & Cellular Proteomics ·John R. Prensner, Jennifer G. Abelin, (unknown), Karl R. Clauser, Jonathan M. Mudge, Jorge Ruiz‐Orera, Michal Bassani‐Sternberg, Robert L. Moritz, Eric W. Deutsch, Sebastiaan van Heesch	46
6	1040-B Identifying tumor-associated antigens in different stages of multiple myeloma using low input HLA immunopeptidomics 2023 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), (unknown), Claudia Ctortecka, (unknown), Karl R. Clauser, Namrata D. Udeshi, Jennifer G. Abelin, Elisabet E. Manasanch, Steven A. Carr	1
7	TAILS Identifies Candidate Substrates and Biomarkers of ADAMTS7, a Therapeutic Protease Target in Coronary Artery Disease 2022 ·Molecular & Cellular Proteomics ·Bryan T. MacDonald, Hasmik Keshishian, (unknown), Alessandro Arduini, (unknown), (unknown), (unknown), (unknown), Karl R. Clauser, Harrison Specht, Nadine H. Elowe, (unknown), (unknown), Virendar K. Kaushik, Steven A. Carr, Patrick T. Ellinor	10
8	Cancer proteogenomics: current impact and future prospects 2022 ·Nature reviews. Cancer ·D.R. Mani, Karsten Krug, Bing Zhang, Shankha Satpathy, Karl R. Clauser, Li Ding, Matthew J. Ellis, Michael A. Gillette, Steven A. Carr	119
9	Comparative Analysis of Mitochondrial N-Termini from Mouse, Human, and Yeast 2017 ·Molecular & Cellular Proteomics ·Sarah E. Calvo, Olivier Julien, Karl R. Clauser, Hongying Shen, Kimberli J. Kamer, James A. Wells, Vamsi K. Mootha	66
10	Quantitative proteomic profiling of the extracellular matrix of pancreatic islets during the angiogenic switch and insulinoma progression 2017 ·Nature ·Karl R. Clauser, D.R. Mani, Steven A. Carr, Alexandra Naba, Richard O. Hynes	1
11	Site-specific identification and quantitation of endogenous SUMO modifications under native conditions 2017 ·Nature Communications ·Ryan J. Lumpkin, Hongbo Gu, Yiying Zhu, Marilyn Leonard, (unknown), Karl R. Clauser, Jesse G. Meyer, Eric J. Bennett, Elizabeth A. Komives	103
12	Methods, Tools and Current Perspectives in Proteogenomics 2017 ·Molecular & Cellular Proteomics ·Kelly V. Ruggles, Karsten Krug, Xiaojing Wang, Karl R. Clauser, Jing Wang, Samuel Payne, David Fenyö, Bing Zhang, D.R. Mani	104
13	Quantitative, multiplexed workflow for deep analysis of human blood plasma and biomarker discovery by mass spectrometry 2017 ·Nature Protocols ·Hasmik Keshishian, Michael Burgess, Harrison Specht, (unknown), Karl R. Clauser, Michael A. Gillette, Steven A. Carr	125
14	An Integrative Framework Reveals Signaling-to-Transcription Events in Toll-like Receptor Signaling 2017 ·Cell Reports ·Philipp Mertins, Dariusz Przybylski, Nir Yosef, Jana Qiao, Karl R. Clauser, Raktima Raychowdhury, Thomas Eisenhaure, Tanja Maritzen, Volker Haucke, Takashi Satoh, Shizuo Akira, Steven A. Carr, Aviv Regev, Nir Hacohen, Nicolas Chevrier	23
15	Sequencing-Grade De novo Analysis of MS/MS Triplets (CID/HCD/ETD) From Overlapping Peptides 2013 ·Journal of Proteome Research ·Adrian Guthals, Karl R. Clauser, Ari Frank, Nuno Bandeira	52
16	Modification Site Localization Scoring: Strategies and Performance 2012 ·Molecular & Cellular Proteomics ·Robert J. Chalkley, Karl R. Clauser	89
17	iPRG 2011: A study on the identification of electron transfer dissociation (ETD) mass spectra 2011 ·Journal of Biomolecular Techniques JBT ·Lennart Martens, Manor Askenazi, Nuno Bandeira, Robert J. Chalkley, Karl R. Clauser, Eric W. Deutsch, Henry Lam, W. Hayes McDonald, Thomas A. Neubert, Paul A. Rudnick	3
18	Plk1 Self-Organization and Priming Phosphorylation of HsCYK-4 at the Spindle Midzone Regulate the Onset of Division in Human Cells 2009 ·PLoS Biology ·Mark E. Burkard, John Maciejowski, Verónica Rodríguez-Bravo, Michael Repka, Drew M. Lowery, Karl R. Clauser, Chao Zhang, Kevan M. Shokat, Steven A. Carr, Michael B. Yaffe, Prasad V. Jallepalli	145
19	Proteomic and Genetic Approaches Identify Syk as an AML Target 2009 ·Cancer Cell ·Cynthia K. Hahn, Jacob E. Berchuck, Kenneth N. Ross, Rose M. Kakoza, Karl R. Clauser, Anna C. Schinzel, Linda S. Ross, Ilene Galinsky, Tina Davis, Serena J. Silver, David E. Root, Richard M. Stone, Daniel J. DeAngelo, Martin Carroll, William C. Hahn, Steven A. Carr, Todd R. Golub, Andrew L. Kung, Kimberly Stegmaier	120
20	The production and X-ray structure determination of perdeuterated Staphylococcal nuclease 1994 ·Biophysical Chemistry ·Theresa Gamble, Karl R. Clauser, Anthony A. Kossiakoff	32

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact